AKT1 and lung carcinoma: Moreover, we showed that treatment of DDP, the standard chemotherapy reagent of lung cancer, reduced the WT1 expression in lung cancer cells through inhibition of the PI3K/AKT signaling pathway, furthermore, WT1 is a transcriptional factor of AKT, and there is a positive feedback loop between WT1 and AKT expression.